Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01661517 · ClinicalTrials.gov registry record · Early Phase 1
Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting
A Early Phase 1 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Early Phase 1
- Development phase
- 5,271
- Enrollment target
NCT01661517: Clinical Trial Early Phase 1 study, sponsored by University of Alabama at Birmingham.
NCT01661517 is a Early Phase 1 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 5,271 participants, above the 51-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (10235% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01661517, a Early Phase 1 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Early Phase 1
- Development phase
- 5,271 participants
- Enrollment target
Study Summary
This study will be a quality improvement project to review the effectiveness and barriers to effectiveness of a new clinical program in the emergency room to provide substance use screening followed by brief motivational interviewing and referral to treatment for patients who meet criteria for problem substance use. This study will consist of a chart review of the results of the screens performed by substance use counselors and correlating them to institutional variables such as wait time in the emergency room and length of stay as well as to patient variables obtained by chart review such as medical diagnosis and sociodemographic variables.
Interventions
- BEHAVIORAL Motivational interviewing and referral to treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,271 participants |
| Start Date | 2011-09 |
| Est. Completion | 2015-05 |
| Phase | Early Phase 1 |
Why NCT01661517 stopped before completion
NCT01661517 is an interventional study that assigns participants to a tested intervention. Its 5,271 participants enrollment target places it among the larger protocols in the corpus, above the 51-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (10235% higher).
The record links to 0 conditions, and to 1 intervention - of which Motivational interviewing and referral to treatment is the first listed.
NCT01661517 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01661517 about?
NCT01661517 is a clinical study titled "Brief Intervention and Referral to Treatment With Substance Use Disorders in the Emergency Room Setting". This study will be a quality improvement project to review the effectiveness and barriers to effectiveness of a new clinical program in the emergency room to provide substance use screening followed by brief motivational interviewing and referral to treatment for patients who meet criteria for probl...
What is the current status of trial NCT01661517?
This trial is currently terminated. It is a Early Phase 1 study. The enrollment target is 5,271 participants. The study started on 2011-09. Estimated completion is 2015-05.
What interventions are being tested in trial NCT01661517?
The interventions under investigation include: Motivational interviewing and referral to treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT01661517?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01661517's enrollment target sits among peer trials
5,271 1st of 2000 higher than 2,000 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06506344 · 5,250 participants · NA
Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems
- NCT05373771 · 5,328 participants · NA
Sickle Cell Improvement: Enhancing Care in the Emergency Department
- NCT05989308 · 5,200 participants · NA
MyChart Proxy Outreach to Parents (MyPOP)
- NCT06008197 · 5,200 participants · Phase 3
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia